亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Lung sparing in MR-guided non-adaptive SBRT treatment of peripheral lung tumors

医学 核医学 肺癌 肺容积 放射治疗计划 放射治疗 放射科 磁共振成像 内科学
作者
Ho Young Lee,Grace Lee,D. Ferguson,Shu‐Hui Hsu,Yue-Houng Hu,Elizabeth Huynh,Atchar Sudhyadhom,Christopher L. Williams,D.N. Cagney,Kelly Fitzgerald,Benjamin H. Kann,David Kozono,Jonathan E. Leeman,Raymond H. Mak,Zhaohui Han
出处
期刊:Biomedical Physics & Engineering Express [IOP Publishing]
卷期号:10 (4): 045048-045048 被引量:1
标识
DOI:10.1088/2057-1976/ad567d
摘要

Abstract Objective. We aim to: (1) quantify the benefits of lung sparing using non-adaptive magnetic resonance guided stereotactic body radiotherapy (MRgSBRT) with advanced motion management for peripheral lung cancers compared to conventional x-ray guided SBRT (ConvSBRT); (2) establish a practical decision-making guidance metric to assist a clinician in selecting the appropriate treatment modality. Approach. Eleven patients with peripheral lung cancer who underwent breath-hold, gated MRgSBRT on an MR-guided linear accelerator (MR linac) were studied. Four-dimensional computed tomography (4DCT)-based retrospective planning using an internal target volume (ITV) was performed to simulate ConvSBRT, which were evaluated against the original MRgSBRT plans. Metrics analyzed included planning target volume (PTV) coverage, various lung metrics and the generalized equivalent unform dose (gEUD). A dosimetric predictor for achievable lung metrics was derived to assist future patient triage across modalities. Main results. PTV coverage was high (median V100% > 98%) and comparable for both modalities. MRgSBRT had significantly lower lung doses as measured by V20 (median 3.2% versus 4.2%), mean lung dose (median 3.3 Gy versus 3.8 Gy) and gEUD. Breath-hold, gated MRgSBRT resulted in an average reduction of 47% in PTV volume and an average increase of 19% in lung volume. Strong correlation existed between lung metrics and the ratio of PTV to lung volumes (R PTV/Lungs ) for both modalities, indicating that R PTV/Lungs may serve as a good predictor for achievable lung metrics without the need for pre-planning. A threshold value of R PTV/Lungs < 0.035 is suggested to achieve V20 < 10% using ConvSBRT. MRgSBRT should otherwise be considered if the threshold cannot be met. Significance. The benefits of lung sparing using MRgSBRT were quantified for peripheral lung tumors; R PTV/Lungs was found to be an effective predictor for achievable lung metrics across modalities. R PTV/Lungs can assist a clinician in selecting the appropriate modality without the need for labor-intensive pre-planning, which has significant practical benefit for a busy clinic.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
17秒前
Kao应助科研通管家采纳,获得10
40秒前
41秒前
1分钟前
闪闪白柏发布了新的文献求助10
1分钟前
烟消云散完成签到,获得积分10
1分钟前
扯不开的封口膜完成签到,获得积分10
1分钟前
哭泣的雪巧应助闪闪白柏采纳,获得10
1分钟前
万能图书馆应助闪闪白柏采纳,获得10
1分钟前
1分钟前
姚老表完成签到 ,获得积分10
1分钟前
上官若男应助hbx123采纳,获得10
1分钟前
2分钟前
hbx123发布了新的文献求助10
2分钟前
hbx123完成签到,获得积分20
2分钟前
Copyright应助科研通管家采纳,获得10
2分钟前
Nancy0818完成签到 ,获得积分0
3分钟前
葛力完成签到,获得积分10
3分钟前
打打应助黄康采纳,获得10
3分钟前
3分钟前
3分钟前
3分钟前
zachary009完成签到 ,获得积分10
3分钟前
3分钟前
3分钟前
nolan完成签到 ,获得积分10
3分钟前
黄康发布了新的文献求助10
3分钟前
5分钟前
5分钟前
缺角地图完成签到 ,获得积分10
6分钟前
无极微光应助科研通管家采纳,获得20
6分钟前
小蘑菇应助Pengjiajia778852采纳,获得10
6分钟前
墨绾菩提应助科研通管家采纳,获得10
6分钟前
Copyright应助科研通管家采纳,获得10
6分钟前
7分钟前
情怀应助大气大侠采纳,获得10
7分钟前
懒狗羊完成签到,获得积分10
7分钟前
7分钟前
大气大侠发布了新的文献求助10
7分钟前
无花果应助奥润之采纳,获得10
7分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Electrode Potentials 550
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6967953
求助须知:如何正确求助?哪些是违规求助? 8649067
关于积分的说明 18340108
捐赠科研通 6421788
什么是DOI,文献DOI怎么找? 3088372
关于科研通互助平台的介绍 2140012
邀请新用户注册赠送积分活动 2064868